{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:40:26Z","timestamp":1790649626303,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.4065\/81.3.377","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:27:47Z","timestamp":1232760467000},"page":"377-384","source":"Crossref","is-referenced-by-count":42,"title":["B Cells in Health and Disease"],"prefix":"10.4065","volume":"81","author":[{"given":"Robert H.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/81.3.377_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJM200007063430107","article-title":"The immune system: first of two parts","volume":"343","author":"Delves","year":"2000","journal-title":"N Engl J Med"},{"key":"10.4065\/81.3.377_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJM200007133430207","article-title":"The immune system: second of two parts","volume":"343","author":"Delves","year":"2000","journal-title":"N Engl J Med"},{"key":"10.4065\/81.3.377_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Davidson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.4065\/81.3.377_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0952-7915(95)80037-9","article-title":"B cell activation, tolerance and antigen-presenting function","volume":"7","author":"Hodgkin","year":"1995","journal-title":"Curr Opin Immunol"},{"key":"10.4065\/81.3.377_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000082086","article-title":"Regulatory roles for cytokine-producing B cells in infection and autoimmune disease","volume":"8","author":"Lund","year":"2005","journal-title":"Curr Dir Autoimmun"},{"key":"10.4065\/81.3.377_bib6","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus","volume":"189","author":"Chan","year":"1999","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1074-7613(04)00112-8","article-title":"Pathogenic roles of B cells in human autoimmunity; insights from the clinic","volume":"20","author":"Martin","year":"2004","journal-title":"Immunity"},{"issue":"suppl II","key":"10.4065\/81.3.377_bib8","doi-asserted-by":"crossref","first-page":"ii65","DOI":"10.1136\/ard.2004.028282","article-title":"B cell signalling as therapeutic target","volume":"63","author":"Carter","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.4065\/81.3.377_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s11926-004-0010-7","article-title":"B cells: new ways to inhibit their function in rheumatoid arthritis","volume":"6","author":"Carter","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"10.4065\/81.3.377_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd1109","article-title":"Therapeutic strategies for rheumatoid arthritis","volume":"2","author":"Smolen","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.4065\/81.3.377_bib11","series-title":"Kuby Immunology","author":"Goldsby","year":"2000"},{"key":"10.4065\/81.3.377_bib12","series-title":"Medical Immunology","first-page":"66","article-title":"The immune response","author":"Parslow","year":"2001"},{"key":"10.4065\/81.3.377_bib13","author":"IMGT, the international ImMunoGeneTics information system"},{"key":"10.4065\/81.3.377_bib14","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1073\/pnas.81.10.3180","article-title":"Generation of antibody diversity in the immune response of BALB\/c mice to influenza virus hemagglutinin","volume":"81","author":"McKean","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/81.3.377_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1084\/jem.190.5.691","article-title":"Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL\/lpr mice","volume":"190","author":"Brard","year":"1999","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"key":"10.4065\/81.3.377_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1146\/annurev.iy.08.040190.004013","article-title":"Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes","volume":"8","author":"Lanzavecchia","year":"1990","journal-title":"Annu Rev Immunol"},{"key":"10.4065\/81.3.377_bib18","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.4049\/jimmunol.165.10.5558","article-title":"A critical role for B cells in the development of memory CD4 cells","volume":"165","author":"Linton","year":"2000","journal-title":"J Immunol"},{"issue":"suppl 4","key":"10.4065\/81.3.377_bib19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar1010","article-title":"Roles of B cells in rheumatoid arthritis","volume":"5","author":"Silverman","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"10.4065\/81.3.377_bib20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/82717","article-title":"Reciprocal regulation of polarized cytokine production by effector B and T cells","volume":"1","author":"Harris","year":"2000","journal-title":"Nat Immunol"},{"key":"10.4065\/81.3.377_bib21","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.4049\/jimmunol.161.8.3836","article-title":"Transfer of primitive stem\/progenitor bone marrow cells from LT\u03b1-\/- donors to wild-type hosts: implications for the generation of architectural events in lymphoid B cell domains","volume":"161","author":"Mebius","year":"1998","journal-title":"J Immunol"},{"key":"10.4065\/81.3.377_bib22","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.191.11.1813","article-title":"Revising B cell receptors","volume":"191","author":"Nemazee","year":"2000","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib23","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.1086907","article-title":"Predominant autoantibody production by early human B cell precursors","volume":"301","author":"Wardemann","year":"2003","journal-title":"Science"},{"key":"10.4065\/81.3.377_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/intimm\/9.1.27","article-title":"Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone","volume":"9","author":"Chen","year":"1997","journal-title":"Int Immunol"},{"key":"10.4065\/81.3.377_bib25","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1073\/pnas.86.20.8039","article-title":"Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras","volume":"86","author":"Nemazee","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.4065\/81.3.377_bib26","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.4049\/jimmunol.162.5.2655","article-title":"Antigen receptor-induced signal transduction imbalances associated with the negative selection of immature B cells","volume":"162","author":"King","year":"1999","journal-title":"J Immunol"},{"key":"10.4065\/81.3.377_bib27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1084\/jem.177.4.1165","article-title":"B lymphocytes may escape tolerance by revising their antigen receptors","volume":"177","author":"Radic","year":"1993","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1084\/jem.177.4.999","article-title":"Receptor editing: an approach by autoreactive B cells to escape tolerance","volume":"177","author":"Gay","year":"1993","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20011453","article-title":"Autoreactive B cells in the marginal zone that express dual receptors","volume":"195","author":"Li","year":"2002","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.179.1.125","article-title":"Reduced life span of anergic self-reactive B cells in a double-transgenic model","volume":"179","author":"Fulcher","year":"1994","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/35100573","article-title":"From T to B and back again: positive feedback in systemic autoimmune disease","volume":"1","author":"Shlomchik","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.4065\/81.3.377_bib32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.rdc.2004.04.005","article-title":"The stimulation of Toll-like receptors by nuclear antigens: a link between apoptosis and autoimmunity","volume":"30","author":"Marshak-Rothstein","year":"2004","journal-title":"Rheum Dis Clin North Am"},{"key":"10.4065\/81.3.377_bib33","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.4049\/jimmunol.165.3.1626","article-title":"Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells","volume":"165","author":"Rifkin","year":"2000","journal-title":"J Immunol"},{"key":"10.4065\/81.3.377_bib34","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2567.1999.00772.x","article-title":"Do self-perpetuating B lymphocytes drive human autoimmune disease?","volume":"97","author":"Edwards","year":"1999","journal-title":"Immunology"},{"key":"10.4065\/81.3.377_bib35","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.coi.2004.09.007","article-title":"Genetics of human systemic lupus erythematosus: the emerging picture","volume":"16","author":"Nath","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.4065\/81.3.377_bib36","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1084\/jem.173.6.1441","article-title":"An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity","volume":"173","author":"Sobel","year":"1991","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib37","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.4049\/jimmunol.172.11.7192","volume":"172","author":"Su","year":"2004","journal-title":"J Immunol"},{"key":"10.4065\/81.3.377_bib38","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1002\/art.11313","article-title":"A novel polymorphism in the Fc\u03b3 receptor IIB (CD32B) transmembrane region alters receptor signaling","volume":"48","author":"Li","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.4065\/81.3.377_bib39","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1084\/jem.191.11.1881","article-title":"Receptor revision of immunoglobulin heavy chain variable region genes in normal human B lymphocytes","volume":"191","author":"Wilson","year":"2000","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib40","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1006\/jmbi.1998.2396","article-title":"Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire","volume":"285","author":"de Wildt","year":"1999","journal-title":"J Mol Biol"},{"key":"10.4065\/81.3.377_bib41","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/1568010033484124","article-title":"Mechanisms leading to autoantibody production: link between inflammation and autoimmunity","volume":"2","author":"Ohmori","year":"2003","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.4065\/81.3.377_bib42","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1172\/JCI200112462","article-title":"Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance","volume":"108","author":"Pugh-Bernard","year":"2001","journal-title":"J Clin Invest"},{"key":"10.4065\/81.3.377_bib43","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1172\/JCI20255","article-title":"Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells","volume":"113","author":"Zheng","year":"2004","journal-title":"J Clin Invest"},{"key":"10.4065\/81.3.377_bib44","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systematic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib45","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20042321","article-title":"Impaired early B cell tolerance in patients with rheumatoid arthritis","volume":"201","author":"Samuels","year":"2005","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00002281-200305000-00011","article-title":"The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets","volume":"15","author":"Dorner","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.4065\/81.3.377_bib47","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.4049\/jimmunol.152.3.1453","article-title":"B cells process and present lupus autoantigens that initiate autoimmune T cell responses","volume":"152","author":"Mamula","year":"1994","journal-title":"J Immunol"},{"issue":"suppl 1","key":"10.4065\/81.3.377_bib48","first-page":"4","article-title":"The immunopathogenesis of rheumatoid arthritis","volume":"32","author":"Panayi","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.4065\/81.3.377_bib49","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.4049\/jimmunol.167.8.4710","article-title":"T cell activation in rheumatoid synovium is B cell dependent","volume":"167","author":"Takemura","year":"2001","journal-title":"J Immunol"},{"key":"10.4065\/81.3.377_bib50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.173.2.487","article-title":"Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells","volume":"173","author":"Roosnek","year":"1991","journal-title":"J Exp Med"},{"key":"10.4065\/81.3.377_bib51","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.4049\/jimmunol.162.5.3053","article-title":"Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis","volume":"162","author":"Kim","year":"1999","journal-title":"J Immunol"},{"key":"10.4065\/81.3.377_bib52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/ni772","article-title":"How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease","volume":"3","author":"Matsumoto","year":"2002","journal-title":"Nat Immunol"},{"key":"10.4065\/81.3.377_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0065-2776(04)82005-4","article-title":"The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease","volume":"82","author":"Monach","year":"2004","journal-title":"Adv Immunol"},{"key":"10.4065\/81.3.377_bib54","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003495-200363080-00005","article-title":"Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia","volume":"63","author":"Plosker","year":"2003","journal-title":"Drugs"},{"key":"10.4065\/81.3.377_bib55","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/sj.leu.2402639","article-title":"Anti-CD20-based therapy of B cell lymphoma: state of the art","volume":"16","author":"Kosmas","year":"2002","journal-title":"Leukemia"},{"key":"10.4065\/81.3.377_bib56","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1182\/blood.V84.8.2457.2457","article-title":"Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma","volume":"84","author":"Maloney","year":"1994","journal-title":"Blood"},{"key":"10.4065\/81.3.377_bib57","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"issue":"1, suppl 2","key":"10.4065\/81.3.377_bib58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30156","article-title":"Rituximab: mechanism of action and resistance","volume":"29","author":"Maloney","year":"2002","journal-title":"Semin Oncol"},{"key":"10.4065\/81.3.377_bib59","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.4065\/81.3.377_bib60","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N Engl J Med"},{"key":"10.4065\/81.3.377_bib61","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/art.10467","article-title":"Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells","volume":"46","author":"De Vita","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.4065\/81.3.377_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.rhu.0000111316.59676.db","article-title":"Successful therapy of rheumatoid arthritis with rituximab: renewed interest in the role of B cells in the pathogenesis of rheumatoid arthritis","volume":"10","author":"Kramm","year":"2004","journal-title":"J Clin Rheumatol"},{"key":"10.4065\/81.3.377_bib63","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/ard.61.10.883","article-title":"Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion","volume":"61","author":"Leandro","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.4065\/81.3.377_bib64","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/rheumatology\/kei080","article-title":"B-cell depletion in the treatment of patients with systematic lupus erythematosus: a longitudinal analysis of 24 patients","volume":"44","author":"Leandro","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.4065\/81.3.377_bib65","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.20430","article-title":"B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I\/II dose-escalation trial of rituximab","volume":"50","author":"Looney","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.4065\/81.3.377_bib66","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.20858","article-title":"Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial","volume":"52","author":"Sfikakis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.4065\/81.3.377_bib67","unstructured":"Albert D, Khan S, Stansberry J, et al. A phase I trial of rituximab (anti-CD20) for treatment of systematic lupus erythematosus. In: Program and abstracts of the American College of Rheumatology\/Association of Rheumatology Health Professionals 68th Annual Meeting; October 16-21, 2004; San Antonio, Tex. Abstract 1125."},{"key":"10.4065\/81.3.377_bib68","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1182\/blood-2002-02-0392","article-title":"Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura [letter]","volume":"99","author":"Stasi","year":"2002","journal-title":"Blood"},{"key":"10.4065\/81.3.377_bib69","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.4065\/81.3.377_bib70","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1600-6143.2004.00454.x","article-title":"Rituximab as treatment for refractory kidney transplant rejection","volume":"4","author":"Becker","year":"2004","journal-title":"Am J Transplant"},{"key":"10.4065\/81.3.377_bib71","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/art.20849","article-title":"Rituximab in the treatment of dermatomyositis: an open-label pilot study","volume":"52","author":"Levine","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.4065\/81.3.377_bib72","first-page":"A3","article-title":"Rituximab induced depletion of circulating B cells in anti-Hu and anti-Yo associated paraneoplastic neurological syndromes","volume":"60","author":"Smitt","year":"2003","journal-title":"Neurology"},{"key":"10.4065\/81.3.377_bib73","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","article-title":"B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes","volume":"62","author":"Pranzatelli","year":"2004","journal-title":"Neurology"},{"key":"10.4065\/81.3.377_bib74","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/WNL.52.8.1701","article-title":"IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using rituximab","volume":"52","author":"Levine","year":"1999","journal-title":"Neurology"},{"key":"10.4065\/81.3.377_bib75","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jnnp.74.4.485","article-title":"Treatment of IgM antibody associated polyneuropathies using rituximab","volume":"74","author":"Pestronk","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.4065\/81.3.377_bib76","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"issue":"suppl 2","key":"10.4065\/81.3.377_bib77","doi-asserted-by":"crossref","first-page":"ii13","DOI":"10.1093\/rheumatology\/keh618","article-title":"B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis","volume":"44","author":"Looney","year":"2005","journal-title":"Rheumatology"},{"key":"10.4065\/81.3.377_bib78","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/art.11181","article-title":"Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis","volume":"48","author":"Cambridge","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.4065\/81.3.377_bib79","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4049\/jimmunol.174.2.817","article-title":"Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy","volume":"174","author":"Gong","year":"2005","journal-title":"J Immunol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611614663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611614663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T18:59:09Z","timestamp":1684868349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611614663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0025619611614663"],"URL":"https:\/\/doi.org\/10.4065\/81.3.377","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}